{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:41:29Z","timestamp":1790840489916,"version":"4.1.0"},"reference-count":156,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Direct"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In this review, we analyze the epidemiology of thromboses related to end-stage liver disease (ESLD), discuss causes of hypercoagulability, describe susceptible populations, and critically evaluate proposed prophylaxis and treatment of thromboses. Classically, ESLD has been regarded as a model for coagulopathy, and patients were deemed to be at high risk for bleeding complications. Patients with ESLD are not auto-anticoagulated, and they do not have a lower risk of portal vein thrombosis, intracardiac thrombus formation, pulmonary embolism or hepatic artery thrombosis. Though the cause of hypercoagulability is multifactorial, endothelial dysfunction likely plays a central role for all patients with ESLD. Some subpopulations, such as patients with nonalcoholic steatohepatitis and autoimmune conditions, are at increased risk of thrombotic events as are patients of Hispanic ethnicity. The science behind prophylaxis of different types of clotting and treatment of thromboses is developing rapidly. A number of medications, including low molecular weight heparin, unfractionated heparin, aspirin, vitamin K antagonists, and direct oral anticoagulants can be used, but clear guidelines are lacking. Acute intraoperative clotting can be associated with high mortality. Routine use of transesophageal echocardiography can be helpful in early recognition and treatment of intraoperative thrombosis. Heparin should be reserved for cases of intracardiac thrombus\/pulmonary embolism without hemodynamic instability. In unstable patients, low dose of recombinant tissue plasminogen activator can be used. In this new era of heightened awareness of thrombotic events in ESLD patients, prospective randomized trials are urgently needed to best guide clinical practice.<\/jats:p>","DOI":"10.1097\/txd.0000000000000843","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T00:33:29Z","timestamp":1540773209000},"page":"e403","source":"Crossref","is-referenced-by-count":36,"title":["Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management"],"prefix":"10.1097","volume":"4","author":[{"given":"Thomas A.","family":"Verbeek","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Stine","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology & Hepatology, Department of Medicine, The Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuat H.","family":"Saner","sequence":"additional","affiliation":[{"name":"Department of General, Visceral and Transplantation Surgery, Essen University Medical Center, Essen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Bezinover","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine, The Pennsylvania State University-Milton S. Hershey Medical Center, Hershey, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,11]]},"reference":[{"key":"bib1-20231002","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"bib2-20231002","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000088056","article-title":"Minimizing blood loss in liver transplantation: progress through research and evolution of techniques","volume":"22","year":"2005","journal-title":"Dig Surg"},{"key":"bib3-20231002","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"key":"bib4-20231002","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"bib5-20231002","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/bmj.318.7183.593","article-title":"Clinical guidelines: developing guidelines","volume":"318","year":"1999","journal-title":"BMJ"},{"key":"bib6-20231002","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4254\/wjh.v7.i3.443","article-title":"Endothelial dysfunction in cirrhosis: role of inflammation and oxidative stress","volume":"7","year":"2015","journal-title":"World J Hepatol"},{"key":"bib7-20231002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-0038-1655904","article-title":"Ongoing prothrombotic state in the portal circulation of cirrhotic patients","volume":"77","year":"1997","journal-title":"Thromb Haemost"},{"key":"bib8-20231002","first-page":"303","article-title":"Tissue factor pathway inhibitor concentrations in cirrhotic patients with and without portal vein thrombosis","volume":"92","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"bib9-20231002","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cardiores.2004.06.020","article-title":"Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress","volume":"64","year":"2004","journal-title":"Cardiovasc Res"},{"key":"bib10-20231002","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/jhep.2003.50180","article-title":"Peripheral blood mononuclear cell expression of toll-like receptors and relation to cytokine levels in cirrhosis","volume":"37","year":"2003","journal-title":"Hepatology"},{"key":"bib11-20231002","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hep.1840080207","article-title":"Endotoxin levels measured by a chromogenic assay in portal, hepatic and peripheral venous blood in patients with cirrhosis","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"bib12-20231002","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/hep.21905","article-title":"The puzzle of endothelial nitric oxide synthase dysfunction in portal hypertension: the missing piece?","volume":"46","year":"2007","journal-title":"Hepatology"},{"key":"bib13-20231002","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1160\/TH03-05-0310","article-title":"Factor VIII expression in liver disease","volume":"91","year":"2004","journal-title":"Thromb Haemost"},{"key":"bib14-20231002","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/0016-5085(91)90092-Y","article-title":"A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced fibrinolysis in cirrhosis","volume":"101","year":"1991","journal-title":"Gastroenterology"},{"key":"bib15-20231002","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000354400","article-title":"Delicate balance of bleeding and thrombosis in end-stage liver disease and liver transplantation","volume":"88","year":"2013","journal-title":"Digestion"},{"key":"bib16-20231002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"bib17-20231002","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/hep.1840080625","article-title":"Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists","volume":"8","year":"1988","journal-title":"Hepatology"},{"key":"bib18-20231002","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","year":"2001","journal-title":"Blood"},{"key":"bib19-20231002","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.28853","article-title":"Low-grade endotoxemia and platelet activation in cirrhosis","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"bib20-20231002","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/1076029612440034","article-title":"Hypercoagulability in end-stage liver disease: prevalence and its correlation with severity of liver disease and portal vein thrombosis","volume":"18","year":"2012","journal-title":"Clin Appl Thromb Hemost"},{"key":"bib21-20231002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jhep.2009.12.001","article-title":"Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests","volume":"52","year":"2010","journal-title":"J Hepatol"},{"key":"bib22-20231002","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01313579","article-title":"Bleeding after liver biopsy does not correlate with indices of peripheral coagulation","volume":"26","year":"1981","journal-title":"Dig Dis Sci"},{"key":"bib23-20231002","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/liv.12158","article-title":"Clinical utility of viscoelastic tests of coagulation in patients with liver disease","volume":"33","year":"2013","journal-title":"Liver Int"},{"key":"bib24-20231002","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/TP.0000000000002092","article-title":"Perioperative coagulation management in liver transplant recipients","volume":"102","year":"2018","journal-title":"Transplantation"},{"key":"bib25-20231002","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.3748\/wjg.v12.i48.7725","article-title":"New insights into the coagulopathy of liver disease and liver transplantation","volume":"12","year":"2006","journal-title":"World J Gastroenterol"},{"key":"bib26-20231002","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1111\/j.1538-7836.2011.04429.x","article-title":"Hypercoagulability in cirrhosis: causes and consequences","volume":"9","year":"2011","journal-title":"J Thromb Haemost"},{"key":"bib27-20231002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1160\/TH14-01-0032","article-title":"Fibrin clot properties and their modulation in thrombotic disorders","volume":"112","year":"2014","journal-title":"Thromb Haemost"},{"key":"bib28-20231002","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/jth.13278","article-title":"Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen","volume":"14","year":"2016","journal-title":"J Thromb Haemost"},{"key":"bib29-20231002","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.510310213","article-title":"Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis","volume":"31","year":"2000","journal-title":"Hepatology"},{"key":"bib30-20231002","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1586\/17474124.2015.1083856","article-title":"Novel insights into the development of portal vein thrombosis in cirrhosis patients","volume":"9","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"bib31-20231002","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood-2008-01-077909","article-title":"Advances in understanding pathogenic mechanisms of thrombophilic disorders","volume":"112","year":"2008","journal-title":"Blood"},{"key":"bib32-20231002","first-page":"594986","article-title":"Factor v leiden and inflammation","volume":"2012","year":"2012","journal-title":"Thrombosis"},{"key":"bib33-20231002","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1055\/s-2007-996025","article-title":"Epidemiology of factor V Leiden: clinical implications","volume":"24","year":"1998","journal-title":"Semin Thromb Hemost"},{"key":"bib34-20231002","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.20166","article-title":"Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C","volume":"39","year":"2004","journal-title":"Hepatology"},{"key":"bib35-20231002","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.transproceed.2012.10.058","article-title":"Factor V Leiden mutation is a risk factor for hepatic artery thrombosis in liver transplantation","volume":"45","year":"2013","journal-title":"Transplant Proc"},{"key":"bib36-20231002","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/01.meg.0000170927.60979.1d","article-title":"Portal vein thrombosis: what is the role of genetics?","volume":"17","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"bib37-20231002","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2004.01.001","article-title":"Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis","volume":"40","year":"2004","journal-title":"J Hepatol"},{"key":"bib38-20231002","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1365-2036.2011.04627.x","article-title":"Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis","volume":"33","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"bib39-20231002","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jcla.21723","article-title":"High frequency of antiphospholipid antibodies in primary biliary cirrhosis","volume":"29","year":"2015","journal-title":"J Clin Lab Anal"},{"key":"bib40-20231002","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1572-0241.1999.01447.x","article-title":"Anticardiolipin antibodies in patients with liver disease","volume":"94","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"bib41-20231002","doi-asserted-by":"crossref","first-page":"e496","DOI":"10.1097\/MD.0000000000000496","article-title":"Associations of antiphospholipid antibodies with splanchnic vein thrombosis: a systematic review with meta-analysis","volume":"94","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"bib42-20231002","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/archinte.158.6.585","article-title":"Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study","volume":"158","year":"1998","journal-title":"Arch Intern Med"},{"key":"bib43-20231002","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archinte.160.6.809","article-title":"Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study","volume":"160","year":"2000","journal-title":"Arch Intern Med"},{"key":"bib44-20231002","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1001\/archinte.167.9.935","article-title":"Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom","volume":"167","year":"2007","journal-title":"Arch Intern Med"},{"key":"bib45-20231002","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1007\/s10620-008-0265-3","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhosis patients","volume":"53","year":"2008","journal-title":"Dig Dis Sci"},{"key":"bib46-20231002","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ajg.2008.34","article-title":"Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study","volume":"104","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"bib47-20231002","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1038\/ctg.2015.27","article-title":"Cirrhosis is associated with an increased 30-day mortality after venous thromboembolism","volume":"6","year":"2015","journal-title":"Clin Transl Gastroenterol"},{"key":"bib48-20231002","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.cgh.2010.05.014","article-title":"Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study","volume":"8","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib49-20231002","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cgh.2013.02.026","article-title":"Coagulation in liver disease: a guide for the clinician","volume":"11","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib50-20231002","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1378\/chest.09-2177","article-title":"Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease","volume":"137","year":"2010","journal-title":"Chest"},{"key":"bib51-20231002","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1016\/j.transproceed.2010.07.063","article-title":"Vascular complications after orthotopic liver transplantation: hepatic artery thrombosis","volume":"42","year":"2010","journal-title":"Transplant Proc"},{"key":"bib52-20231002","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/lt.22105","article-title":"Portal vein thrombosis and liver transplant survival benefit","volume":"16","year":"2010","journal-title":"Liver Transpl"},{"key":"bib53-20231002","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.hpb.2015.10.008","article-title":"Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients","volume":"18","year":"2016","journal-title":"HPB (Oxford)"},{"key":"bib54-20231002","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/lt.500030401","article-title":"Portal vein complications after liver transplantation for biliary atresia","volume":"3","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"bib55-20231002","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.4254\/wjh.v7.i27.2774","article-title":"Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: a meta-analysis","volume":"7","year":"2015","journal-title":"World J Hepatol"},{"key":"bib56-20231002","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/jlts.2001.26928","article-title":"Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation","volume":"7","year":"2001","journal-title":"Liver Transpl"},{"key":"bib57-20231002","first-page":"1608","article-title":"Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs","volume":"101","year":"2005","journal-title":"Anesth Analg"},{"key":"bib58-20231002","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/bja\/aer392","article-title":"Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors","volume":"108","year":"2012","journal-title":"Br J Anaesth"},{"key":"bib59-20231002","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.jvca.2015.09.009","article-title":"Liver transplantation: intraoperative transesophageal echocardiography findings and relationship to major postoperative adverse cardiac events","volume":"30","year":"2016","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"bib60-20231002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.transproceed.2012.06.060","article-title":"Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review","volume":"45","year":"2013","journal-title":"Transplant Proc"},{"key":"bib61-20231002","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jamcollsurg.2008.12.032","article-title":"Vascular complications of orthotopic liver transplantation: experience in more than 4,200 patients","volume":"208","year":"2009","journal-title":"J Am Coll Surg"},{"key":"bib62-20231002","first-page":"26","article-title":"Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: a UNOS database analysis","volume":"16","year":"2016","journal-title":"BMC Anesthesiol"},{"key":"bib63-20231002","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/ctr.12412","article-title":"Hepatic arterial complications in adult living donor liver transplant recipients: a single-center experience of 673 cases","volume":"28","year":"2014","journal-title":"Clin Transplant"},{"key":"bib64-20231002","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1600-6143.2008.02541.x","article-title":"Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"key":"bib65-20231002","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1097\/TP.0000000000001395","article-title":"Preoperative thromboelastography as a sensitive tool predicting those at risk of developing early hepatic artery thrombosis after adult liver transplantation","volume":"100","year":"2016","journal-title":"Transplantation"},{"key":"bib66-20231002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cld.2016.12.003","article-title":"Coagulopathy before and after liver transplantation: from the hepatic to the systemic circulatory systems","volume":"21","year":"2017","journal-title":"Clin Liver Dis"},{"key":"bib67-20231002","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41424-018-0002-y","article-title":"Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis","volume":"9","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"key":"bib68-20231002","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1002\/lt.24134","article-title":"Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis","volume":"21","year":"2015","journal-title":"Liver Transpl"},{"key":"bib69-20231002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2014.03.013","article-title":"Procoagulant imbalance in patients with non-alcoholic fatty liver disease","volume":"61","year":"2014","journal-title":"J Hepatol"},{"key":"bib70-20231002","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1478-3231.2010.02375.x","article-title":"Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease","volume":"31","year":"2011","journal-title":"Liver Int"},{"key":"bib71-20231002","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.jhep.2016.06.001","article-title":"Preserved hemostatic status in patients with non-alcoholic fatty liver disease","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"bib72-20231002","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1097\/TP.0000000000001808","article-title":"The Authors' Response","volume":"101","year":"2017","journal-title":"Transplantation"},{"key":"bib73-20231002","first-page":"171","article-title":"Autoimmune diseases and venous thromboembolism: a review of the literature","volume":"2","year":"2012","journal-title":"Am J Cardiovasc Dis"},{"key":"bib74-20231002","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3748\/wjg.v12.i10.1607","article-title":"Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis","volume":"12","year":"2006","journal-title":"World J Gastroenterol"},{"key":"bib75-20231002","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","article-title":"Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations","volume":"5","year":"2013","journal-title":"World J Hepatol"},{"key":"bib76-20231002","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.510230201","article-title":"Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome","volume":"23","year":"1996","journal-title":"Hepatology"},{"key":"bib77-20231002","first-page":"550","article-title":"Increased rate of thrombin generation in hepatitis C virus cirrhotic patients. Relationship to venous thrombosis","volume":"43","year":"1995","journal-title":"J Investig Med"},{"key":"bib78-20231002","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/jth.12464","article-title":"Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study","volume":"12","year":"2014","journal-title":"J Thromb Haemost"},{"issue":"Suppl 4","key":"bib79-20231002","first-page":"S11","article-title":"Effects of race and ethnicity on the incidence of venous thromboembolism","volume":"123","year":"2009","journal-title":"Thromb Res"},{"key":"bib80-20231002","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1111\/j.1538-7836.2011.04443.x","article-title":"Racial differences in venous thromboembolism","volume":"9","year":"2011","journal-title":"J Thromb Haemost"},{"key":"bib81-20231002","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.hpb.2017.04.002","article-title":"African Americans have a lower prevalence of portal vein thrombosis at the time of liver transplantation","volume":"19","year":"2017","journal-title":"HPB (Oxford)"},{"key":"bib82-20231002","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/liv.12140","article-title":"Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient","volume":"33","year":"2013","journal-title":"Liver Int"},{"key":"bib83-20231002","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jhm.2086","article-title":"Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease","volume":"8","year":"2013","journal-title":"J Hosp Med"},{"key":"bib84-20231002","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/liv.12211","article-title":"Prophylactic anticoagulation for venous thromboembolism in hospitalized cirrhosis patients is not associated with high rates of gastrointestinal bleeding","volume":"34","year":"2014","journal-title":"Liver Int"},{"key":"bib85-20231002","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/jth.13000","article-title":"Safety and efficacy of pharmacological thromboprophylaxis for hospitalized patients with cirrhosis: a single-center retrospective cohort study","volume":"13","year":"2015","journal-title":"J Thromb Haemost"},{"key":"bib86-20231002","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/1060028016631760","article-title":"Anticoagulation in patients with cirrhosis: caught between a rock-liver and a hard place","volume":"50","year":"2016","journal-title":"Ann Pharmacother"},{"key":"bib87-20231002","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jhep.2013.03.027","article-title":"Established and new-generation antithrombotic drugs in patients with cirrhosis\u2014possibilities and caveats","volume":"59","year":"2013","journal-title":"J Hepatol"},{"key":"bib88-20231002","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1016\/j.transproceed.2009.04.011","article-title":"Administration of dalteparin based on the activated clotting time for prophylaxis of hepatic vessel thrombosis in living donor liver transplantation","volume":"41","year":"2009","journal-title":"Transplant Proc"},{"key":"bib89-20231002","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1478-3231.2010.02358.x","article-title":"Low-molecular-weight heparin in patients with advanced cirrhosis","volume":"31","year":"2011","journal-title":"Liver Int"},{"key":"bib90-20231002","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1177\/0897190015611570","article-title":"A retrospective cohort analysis of pharmacologic VTE prophylaxis and padua prediction score in hospitalized patients with chronic liver disease","volume":"30","year":"2017","journal-title":"J Pharm Pract"},{"key":"bib91-20231002","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11938-016-0092-0","article-title":"Direct oral anticoagulants in cirrhosis","volume":"14","year":"2016","journal-title":"Curr Treat Options Gastroenterol"},{"key":"bib92-20231002","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1182\/blood-2005-04-1546","article-title":"Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis","volume":"106","year":"2005","journal-title":"Blood"},{"key":"bib93-20231002","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"bib94-20231002","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/ejh.12844","article-title":"The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis","volume":"98","year":"2017","journal-title":"Eur J Haematol"},{"key":"bib95-20231002","article-title":"Liver cirrhosis in patients with atrial fibrillation: would oral anticoagulation have a net clinical benefit for stroke prevention?","volume":"6","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"bib96-20231002","doi-asserted-by":"crossref","first-page":"e88390","DOI":"10.1371\/journal.pone.0088390","article-title":"Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"bib97-20231002","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s10620-015-4012-2","article-title":"Direct oral anticoagulants in cirrhosis patients pose similar risks of bleeding when compared to traditional anticoagulation","volume":"61","year":"2016","journal-title":"Dig Dis Sci"},{"key":"bib98-20231002","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/0091270008324179","article-title":"Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment","volume":"48","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"bib99-20231002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2165\/11318170-000000000-00000","article-title":"Influence of renal impairment on the pharmacokinetics and pharmacodynamics of oral dabigatran etexilate: an open-label, parallel-group, single-centre study","volume":"49","year":"2010","journal-title":"Clin Pharmacokinet"},{"key":"bib100-20231002","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/VHRM.S138890","article-title":"Reversal of direct oral anticoagulants","volume":"13","year":"2017","journal-title":"Vasc Health Risk Manag"},{"key":"bib101-20231002","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal\u2014full cohort analysis","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"bib102-20231002","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/lt.24708","article-title":"Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: a step forward","volume":"23","year":"2017","journal-title":"Liver Transpl"},{"key":"bib103-20231002","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/hep.27225","article-title":"Treating thrombosis in cirrhosis patients with new oral agents: ready or not?","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"bib104-20231002","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/jcph.550","article-title":"An open-label, phase 1 study to evaluate the effects of hepatic impairment on edoxaban pharmacokinetics and pharmacodynamics","volume":"55","year":"2015","journal-title":"J Clin Pharmacol"},{"key":"bib105-20231002","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hep.27350","article-title":"Decreased in vitro anticoagulant potency of rivaroxaban and apixaban in plasma from patients with cirrhosis","volume":"61","year":"2015","journal-title":"Hepatology"},{"key":"bib106-20231002","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.thromres.2008.02.017","article-title":"Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran","volume":"123","year":"2009","journal-title":"Thromb Res"},{"key":"bib107-20231002","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/heartjnl-2013-305288","article-title":"Risk of drug-induced liver injury with the new oral anticoagulants: systematic review and meta-analysis","volume":"100","year":"2014","journal-title":"Heart"},{"key":"bib108-20231002","first-page":"e23539","article-title":"The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations","volume":"14","year":"2014","journal-title":"Hepat Mon"},{"key":"bib109-20231002","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/gut.44.2.270","article-title":"Anti-inflammatory drugs and variceal bleeding: a case-control study","volume":"44","year":"1999","journal-title":"Gut"},{"key":"bib110-20231002","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","article-title":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis","volume":"53","year":"2010","journal-title":"J Hepatol"},{"key":"bib111-20231002","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCG.0b013e3182371258","article-title":"Coronary artery stents and antiplatelet therapy in patients with cirrhosis","volume":"46","year":"2012","journal-title":"J Clin Gastroenterol"},{"key":"bib112-20231002","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/lt.21028","article-title":"Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation?","volume":"13","year":"2007","journal-title":"Liver Transpl"},{"key":"bib113-20231002","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/lt.500030608","article-title":"Low-dose aspirin therapy is associated with few side effects but does not prevent hepatic artery thrombosis in liver transplant recipients","volume":"3","year":"1997","journal-title":"Liver Transpl Surg"},{"key":"bib114-20231002","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archsurg.139.10.1069","article-title":"Ischemic arterial complications after liver transplantation in the adult: multivariate analysis of risk factors","volume":"139","year":"2004","journal-title":"Arch Surg"},{"key":"bib115-20231002","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3350\/cmh.2016.0110","article-title":"Anticoagulation in cirrhosis: a new paradigm?","volume":"23","year":"2017","journal-title":"Clin Mol Hepatol"},{"key":"bib116-20231002","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"bib117-20231002","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/gastro\/gox014","article-title":"Portal vein thrombosis in patients with cirrhosis","volume":"5","year":"2017","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"bib118-20231002","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gut.2004.042796","article-title":"Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation","volume":"54","year":"2005","journal-title":"Gut"},{"key":"bib119-20231002","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MEG.0000000000000482","article-title":"Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis","volume":"28","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"bib120-20231002","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/jamainternmed.2015.3184","article-title":"Long-term clinical outcomes of splanchnic vein thrombosis: results of an international registry","volume":"175","year":"2015","journal-title":"JAMA Intern Med"},{"key":"bib121-20231002","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/MEG.0000000000000351","article-title":"Efficacy and safety of anticoagulation therapy with different doses of enoxaparin for portal vein thrombosis in cirrhotic patients with hepatitis B","volume":"27","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"bib122-20231002","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/hepr.12400","article-title":"Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis","volume":"45","year":"2015","journal-title":"Hepatol Res"},{"key":"bib123-20231002","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.dld.2013.08.138","article-title":"Impact of portal vein thrombosis on the efficacy of endoscopic variceal band ligation","volume":"46","year":"2014","journal-title":"Dig Liver Dis"},{"key":"bib124-20231002","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s10620-012-2548-y","article-title":"Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation","volume":"58","year":"2013","journal-title":"Dig Dis Sci"},{"key":"bib125-20231002","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1478-3231.2012.02785.x","article-title":"Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis","volume":"32","year":"2012","journal-title":"Liver Int"},{"key":"bib126-20231002","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCG.0b013e3181b3ab44","article-title":"Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis","volume":"44","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"bib127-20231002","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","year":"1999","journal-title":"N Engl J Med"},{"key":"bib128-20231002","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejim.2014.12.002","article-title":"Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies","volume":"26","year":"2015","journal-title":"Eur J Intern Med"},{"key":"bib129-20231002","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.27783","article-title":"Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study","volume":"62","year":"2015","journal-title":"Hepatology"},{"key":"bib130-20231002","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1161\/CIRCULATIONAHA.111.029017","article-title":"Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects","volume":"124","year":"2011","journal-title":"Circulation"},{"key":"bib131-20231002","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/jth.12599","article-title":"Comparison of three-factor and four-factor prothrombin complex concentrates regarding reversal of the anticoagulant effects of rivaroxaban in healthy volunteers","volume":"12","year":"2014","journal-title":"J Thromb Haemost"},{"key":"bib132-20231002","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2036.2006.02820.x","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without cavernous transformation","volume":"23","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"bib133-20231002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00270-006-0321-3","article-title":"Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with and without underlying cirrhosis","volume":"30","year":"2007","journal-title":"Cardiovasc Intervent Radiol"},{"key":"bib134-20231002","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00270-005-0090-4","article-title":"Transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis and concomitant portal vein thrombosis","volume":"29","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"bib135-20231002","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/gut.2010.228023","article-title":"Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis","volume":"60","year":"2011","journal-title":"Gut"},{"key":"bib136-20231002","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.tvir.2016.01.006","article-title":"Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations","volume":"19","year":"2016","journal-title":"Tech Vasc Interv Radiol"},{"key":"bib137-20231002","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/TP.0000000000000729","article-title":"Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis","volume":"99","year":"2015","journal-title":"Transplantation"},{"key":"bib138-20231002","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1148\/radiol.2015150369","article-title":"Is post-TIPS anticoagulation therapy necessary in patients with cirrhosis and portal vein thrombosis? A randomized controlled trial","volume":"279","year":"2016","journal-title":"Radiology"},{"key":"bib139-20231002","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.3748\/wjg.v20.i19.5737","article-title":"Deep vein thrombosis and pulmonary embolism in cirrhotic patients: systematic review","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"bib140-20231002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1345\/aph.1R496","article-title":"Risk factors for venous thromboembolism in patients with chronic liver disease","volume":"47","year":"2013","journal-title":"Ann Pharmacother"},{"key":"bib141-20231002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000442877","article-title":"The complex role of anticoagulation in cirrhosis: an updated review of where we are and where we are going","volume":"93","year":"2016","journal-title":"Digestion"},{"key":"bib142-20231002","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.3748\/wjg.v16.i17.2146","article-title":"Prophylaxis for venous thromboembolism after resection of hepatocellular carcinoma on cirrhosis: is it necessary?","volume":"16","year":"2010","journal-title":"World J Gastroenterol"},{"key":"bib143-20231002","first-page":"259","article-title":"Venous thromboembolism and liver cirrhosis","volume":"100","year":"2008","journal-title":"Rev Esp Enferm Dig"},{"key":"bib144-20231002","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1538-7836.2008.02831.x","article-title":"Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review","volume":"6","year":"2008","journal-title":"J Thromb Haemost"},{"key":"bib145-20231002","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1213\/ANE.0b013e31820472d4","article-title":"The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac\/pulmonary thrombosis during liver transplantation","volume":"112","year":"2011","journal-title":"Anesth Analg"},{"key":"bib146-20231002","first-page":"6268370","article-title":"Emergent management of intracardiac thrombosis during liver transplantation","volume":"2016","year":"2016","journal-title":"Case Rep Transplant"},{"key":"bib147-20231002","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0735-1097(94)90113-9","article-title":"Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk","volume":"24","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"bib148-20231002","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00000542-200209000-00059","article-title":"ECMO resuscitation after massive pulmonary embolism during liver transplantation","volume":"97","year":"2002","journal-title":"Anesthesiology"},{"key":"bib149-20231002","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1161\/01.CIR.99.21.2779","article-title":"Free-floating thrombi in the right heart: diagnosis, management, and prognostic indexes in 38 consecutive patients","volume":"99","year":"1999","journal-title":"Circulation"},{"key":"bib150-20231002","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0735-1097(02)02381-1","article-title":"Thrombolytic therapy of pulmonary embolism: a meta-analysis","volume":"40","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"bib151-20231002","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.3748\/wjg.v21.i26.8004","article-title":"Perioperative thrombotic complications in liver transplantation","volume":"21","year":"2015","journal-title":"World J Gastroenterol"},{"key":"bib152-20231002","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.4254\/wjh.v7.i9.1238","article-title":"Anticoagulation and antiplatelets as prophylaxis for hepatic artery thrombosis after liver transplantation","volume":"7","year":"2015","journal-title":"World J Hepatol"},{"key":"bib153-20231002","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1016\/S0041-1345(02)03576-5","article-title":"Anticoagulant therapy against hepatic artery thrombosis in living donor liver transplantation","volume":"34","year":"2002","journal-title":"Transplant Proc"},{"key":"bib154-20231002","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00007890-199511270-00009","article-title":"Prevention of hepatic artery thrombosis in pediatric liver transplantation","volume":"60","year":"1995","journal-title":"Transplantation"},{"key":"bib155-20231002","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.transproceed.2012.05.075","article-title":"Early aspirin therapy may reduce hepatic artery thrombosis in liver transplantation","volume":"45","year":"2013","journal-title":"Transplant Proc"},{"key":"bib156-20231002","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/tri.12855","article-title":"Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis","volume":"29","year":"2016","journal-title":"Transpl Int"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01845228-201811000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:57:44Z","timestamp":1786039064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01845228-201811000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":156,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000000843","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]}}}